Patent Assignment
Reel/Frame 021890/0102
Security Agreement
Recorded: 2008-11-25
Pages: 4
Assignor
BIOMEDICAL FRONTIERS INCORPORATED
Executed: 2008-11-21
Assignee
THERAPURE BIOPHARMA INC.
2585 MEADOWPINE BLVD., MISSISSAUGA, ONTARIO, L5N 8H9, CANADA
Covered Properties
(5)
Polymer-Deferoxamine-Ferric Iron Adducts for Use in Magnetic Resonance Imaging
Patent:
5,268,165 →
Application:
07/926,906 →
Combined Treatment of Iron Depletion and Igg Antibody
Patent:
5,762,932 →
Application:
08/718,293 →
Method of Reducing a Schiff Base
Patent:
5,847,110 →
Application:
08/911,991 →
Modified Polysaccharides Exhibiting Altered Biological Recognition
Patent:
6,479,468 →
Application:
09/555,994 →
Modified Polysaccharides Exhibiting Altered Biological Recognition
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 20, 2008
From: HEDLUND, BO L.; WEBER, THOMAS P.; DRAGSTEN, PAUL R.; HANSON, GREGORY J.
To: BIOMEDICAL FRONTIERS INCORPORATED
Reel/Frame 021861/0289 →
Assignment of Assignor's Interest
Nov 18, 2011
From: BIOMEDICAL FRONTIERS, INCORPORATED
To: THERAPURE BIOPHARMA INC.
Reel/Frame 027254/0754 →
Security Interest
Nov 23, 2015
From: THERAPURE BIOPHARMA INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037116/0471 →
Assignment of Assignor's Interest
Dec 14, 2015
From: BIOMEDICAL FRONTIERS, INCORPORATED
To: THERAPURE BIOPHARMA INC.
Reel/Frame 037281/0151 →